Mr Ice Cream Glove posted:

Breitbart

https://twitter.com/alozrasT7/status/942863260579258368?s=17

canepazzo posted:

https://twitter.com/chrisgeidner/status/942876349756141568

It really was Jill not Hill, indeed.

Mr Ice Cream Glove posted:

Breitbart

https://twitter.com/alozrasT7/status/942863260579258368?s=17

Blitz7x posted:

I hope Trump gets a Certificate of Exoneration® and all the benefits that come with it none

Night10194 posted:

Remember when his letter firing Comey thanked him for all the times he told him he wasn't under personal investigation, lol

Snacksmaniac posted:

Didn’t comet tell him three times that he wasn’t under investigation according no one ?

publishko posted:

...is there any precedent for giving someone a letter exonerating them of any wrongdoing? do prosecutors do such things?

quote:

Dear Your Excellency, His Honorable President Mr Trump:

You're innocent!!! Investigation over. Lock her up.

Love, Bob (Mueller)

moostaffa posted:

What's wrong with Collins btw? She speaks like she has some kind of condition

publishko posted:

...is there any precedent for giving someone a letter exonerating them of any wrongdoing? do prosecutors do such things?

Pakled posted:

I think what happened was Comey, almost certainly after being specifically asked by Trump, repeatedly told him he was not personally under investigation, but rather, his campaign was, and Trump repeatedly heralded the first half the statement publicly as a sign that he was totally in the clear, and also kept asking because he was hoping that doing so might magically change the answer.

Smol posted:

Have the Democrats introduced an alternative, real tax reform idea? You’d think that something like that right now could be easy points for them.

quote:

For four decades, Don Anderson of Seattle has been taking the same drug to help control the temporary bouts of immobility and muscle weakness caused by a rare genetic illness called periodic paralysis.

"It's like putting a 50-pound pack on your back and standing up at the dinner table," Anderson, 73, said. "It's like wearing lead shoes around all the time."

The drug Anderson has been taking all these years was originally approved in 1958 and used primarily to treat the eye disease glaucoma under the brand name Daranide, its price so unremarkable that he can't quite remember how much it cost at the pharmacy counter.

But the price has been on a roller coaster in recent years — zooming from a list price of $50 for a bottle of 100 pills in the early 2000s up to $13,650 in 2015, then plummeting back down to free, before skyrocketing back up to $15,001 after a new company, Strongbridge Biopharma, acquired the drug and relaunched it this spring.

"I'm constantly hearing that public pressure, public shaming will be sufficient to curb these bad actors in these industries. It often feels if you take your attention off of them, even for a second, they'll revert to these old ways," said Rachel Sachs, an associate law professor at Washington University in St. Louis. "It's just another example of how the system has some problems that need to be fixed."

quote:

In the early 2000s, Daranide was discontinued by Merck. Other glaucoma treatments were available, but a small group of periodic paralysis patients who had found that it controlled their symptoms better than other drugs were left with few options. They found ways to get the drug, importing it from Europe or South Korea. Anderson recalls the expense as about $250 or $300 a month.

In 2008, a family affected by the disease that also owned Taro Pharmaceutical Industries, a generic pharmaceutical company, decided to acquire Daranide from Merck. The goal was to make the drug reliably available to patients at a reasonable cost, Barrie Levitt, the former chairman of the company, and his son Jacob said in 2016.

Jacob suffers from periodic paralysis, and although he took a different drug to control his disease, he became aware from his work in the patient advocacy community that Daranide had been discontinued, forcing patients to look for alternatives or find sources to import. He said Taro spent less than half a million dollars to acquire the old drug.

But Taro was taken over by another generic-drug company, Sun Pharmaceutical Industries, in 2010. When the drug was approved in 2015 as a rare-disease treatment for periodic paralysis, it got a new name, Keveyis, and a new price: $13,650 for 100 pills. Although Keveyis is a decades-old drug, its federal approval for periodic paralysis came with a seven-year period of exclusive marketing rights.

Smol posted:

Have the Democrats introduced an alternative, real tax reform idea? You’d think that something like that right now could be easy points for them.

Nissin Cup Nudist posted:

Who is moving to Detroit in bulk to gentrify it? No one is running a car start-up.

The Glumslinger posted:

http://www.latimes.com/business/la-fi-drug-price-20171218-story.html


Nah, this is totally good, companies should totally be allowed to buy 60 year old drugs, and jack up the prices 100X times

The Glumslinger posted:

zooming from a list price of $50 for a bottle of 100 pills in the early 2000s up to $13,650 in 2015, then plummeting back down to free, before skyrocketing back up to $15,001 after a new company, Strongbridge Biopharma, acquired the drug and relaunched it this spring.

Rigel posted:

Sure they can, and sometimes do when the target of an investigation is later determined to be likely innocent. It doesn't legally mean much though, and if they suddenly find a smoking gun proving you were guilty all along they can go "wait, never mind, we're prosecuting you."

Smol posted:

Have the Democrats introduced an alternative, real tax reform idea? You’d think that something like that right now could be easy points for them.

Ague Proof posted:

Rinkles posted:

There aren't generics for 60 year old drugs?

quote:

In 2016, after the Washington Post asked questions about the high price of the drug, Sun Pharmaceutical said it would give the drug away free of charge. Sun said that the timing was coincidental and reflected the fact that the company had made less than $1 million on the drug — not enough to recoup the investment the company had made in marketing and patient support services.

But the story doesn't end there. Late last year, Sun agreed to sell Keveyis to a biotech company, Strongbridge Biopharma, for $8.5 million. In April, Strongbridge relaunched the drug — and in August, it raised the list price to $15,001 for a bottle of 100 pills.

In a presentation for investors, Strongbridge Biopharma estimated that the annual price of treatment for Keveyis would range from $109,500 to $219,000, depending on the dosage the patient took. One slide shows that the drug is covered broadly by insurers. In November, the company announced $2.5 million in sales last quarter — a 67% increase over the previous quarter's $1.5 million in sales. It said it would expand its sales force, and executives said in a conference call that the company's medical affairs team had met with 75 medical leaders and was training speakers to lead "peer-to-peer educational programs."

Phelddagrif posted:

There's not much point in doing that, both because it's easy (just adjust some rates and expand some credits) and because it's boring and doesn't get the base riled up. "Lower the bottom tax rate and raise the top rate" doesn't carry the same level of excitement as "single-payer" or "Medicare for all."

Koalas March posted:

"Although Keveyis is a decades-old drug, its federal approval for periodic paralysis came with a seven-year period of exclusive marketing rights."

Owlofcreamcheese posted:

You can have gentrification without an influx of people if you just have so many people left there isn't much good stuff left in general and the rich people push out the poor people that started it.

Like if there used to be 50 cool bars that was all sorts of people and then all but two closed the people with the most money will probably push their way into both of the two remaining ones till none of the original crowd is even left.

Rinkles posted:

Not sure what that means.

Petr posted:

If Trump presidency years were put into Harry Potter movie terms, Professor Quirrel is just now unwrapping his turban.

Petr posted:

because there are gonna be eight of them, you see

The Glumslinger posted:

Oh sorry, I ended that post too early again


2016- Washington Post calls them out on the crazy markup, they agree to sell the it for free

Then they decide to just sell the rights to the drug to a different company, and now its more expensive than ever.

Koalas March posted:

Exclusive rights means no generics.

Rinkles posted:

Not sure what that means.

Spangly A posted:

It was generic, the holding company discovers a niche use and documents it, absolutely no bribery occurs, and the holding company are allowed to increase price 300x for all uses with generics made illegal for seven years.